IDEXX Laboratories Inc (NASDAQ:IDXX) — Market Cap & Net Worth

$40.24 Billion USD  · Rank #677

Market Cap & Net Worth: IDEXX Laboratories Inc (IDXX)

IDEXX Laboratories Inc (NASDAQ:IDXX) has a market capitalization of $40.24 Billion ($40.24 Billion) as of September 16, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #677 globally and #323 in its home market, demonstrating a -4.60% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying IDEXX Laboratories Inc's stock price $510.73 by its total outstanding shares 78781116 (78.78 Million). Also see IDEXX Laboratories Inc balance sheet assets for a full breakdown of the balance sheet.

IDEXX Laboratories Inc Market Cap History: 2015 to 2026

IDEXX Laboratories Inc's market capitalization history from 2015 to 2026. Data shows growth from $5.74 Billion to $40.24 Billion (19.33% CAGR). Also see IDXX cash flow conversion for how efficiently the company converts equity into cash flow.

Index Memberships

IDEXX Laboratories Inc is a constituent of 4 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
S&P 500 Index
GSPC
$62.85 Trillion 0.07% #240 of 503
NASDAQ Health Care
IXHC
$2.66 Trillion 1.51% #11 of 976
NASDAQ Composite
IXIC
$41.74 Trillion 0.10% #93 of 3165
Nasdaq 100
NDX
$35.08 Trillion 0.11% #75 of 101

Weight: IDEXX Laboratories Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

IDEXX Laboratories Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how IDEXX Laboratories Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check IDXX stock price and chart for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

12.38x

IDEXX Laboratories Inc's market cap is 12.38 times its annual revenue

Industry average: 0.63x Higher than industry average

Latest Price to Earnings (P/E) Ratio

50.31x

IDEXX Laboratories Inc's market cap is 50.31 times its annual earnings

Industry average: 2.27x Higher than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $9.24 Billion $1.78 Billion $222.04 Million 5.20x 41.61x
2017 $12.32 Billion $1.97 Billion $263.14 Million 6.26x 46.82x
2018 $14.65 Billion $2.21 Billion $377.03 Million 6.62x 38.87x
2019 $20.57 Billion $2.41 Billion $427.72 Million 8.55x 48.10x
2020 $39.38 Billion $2.71 Billion $581.78 Million 14.55x 67.69x
2021 $51.87 Billion $3.22 Billion $744.85 Million 16.13x 69.64x
2022 $32.14 Billion $3.37 Billion $679.09 Million 9.54x 47.33x
2023 $43.73 Billion $3.66 Billion $845.04 Million 11.94x 51.75x
2024 $32.57 Billion $3.90 Billion $887.87 Million 8.36x 36.68x
2025 $53.30 Billion $4.30 Billion $1.06 Billion 12.38x 50.31x

Competitor Companies of IDXX by Market Capitalization

Companies near IDEXX Laboratories Inc in the global market cap rankings as of September 16, 2026. Review tangible net worth ratio of IDEXX Laboratories Inc to assess the quality of the company's equity after excluding intangible assets.

Key companies related to IDEXX Laboratories Inc by market ranking:

  • Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #88 globally with a market cap of $224.59 Billion USD.
  • Danaher Corporation (NYSE:DHR): Ranked #161 globally with a market cap of $147.88 Billion USD.
  • WuXi AppTec Co Ltd (SHG:603259): Ranked #476 globally with a market cap of $56.70 Billion USD ( CN¥387.49 Billion CNY).
  • Natera Inc (NASDAQ:NTRA): Ranked #578 globally with a market cap of $47.01 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#88 Thermo Fisher Scientific Inc NYSE:TMO $224.59 Billion $641.39
#161 Danaher Corporation NYSE:DHR $147.88 Billion $209.36
#476 WuXi AppTec Co Ltd SHG:603259 $56.70 Billion CN¥156.67
#578 Natera Inc NASDAQ:NTRA $47.01 Billion $350.78

IDEXX Laboratories Inc Historical Marketcap From 2015 to 2026

Between 2015 and today, IDEXX Laboratories Inc's market cap moved from $5.74 Billion to $ 40.24 Billion, with a yearly change of 19.33%.

Year Market Cap Change (%)
2026 $40.24 Billion -24.51%
2025 $53.30 Billion +63.63%
2024 $32.57 Billion -25.51%
2023 $43.73 Billion +36.06%
2022 $32.14 Billion -38.04%
2021 $51.87 Billion +31.73%
2020 $39.38 Billion +91.43%
2019 $20.57 Billion +40.38%
2018 $14.65 Billion +18.95%
2017 $12.32 Billion +33.35%
2016 $9.24 Billion +60.82%
2015 $5.74 Billion --

End of Day Market Cap According to Different Sources

On Sep 16th, 2026 the market cap of IDEXX Laboratories Inc was reported to be:

Source Market Cap
Yahoo Finance $40.24 Billion USD
MoneyControl $40.24 Billion USD
MarketWatch $40.24 Billion USD
marketcap.company $40.24 Billion USD
Reuters $40.24 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About IDEXX Laboratories Inc

NASDAQ:IDXX USA Diagnostics & Research
Market Cap
$40.24 Billion
Market Cap Rank
#677 Global
#323 in USA
Share Price
$510.73
Change (1 day)
+0.23%
52-Week Range
$504.70 - $766.68
All Time High
$766.68
About

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urin… Read more